Send to

Choose Destination
Ther Apher Dial. 2017 Jun;21(3):218-225. doi: 10.1111/1744-9987.12566.

Efficacy of Substance Removal by Immunoadsorption With a Selective Plasma Separator.

Author information

Department of Blood Purification, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan.
Medical Engineering Center, Medical Hospital of Tokyo Medical and Dental University, Tokyo, Japan.
Kawasumi Laboratories Incorporated, Tokyo, Japan.
Department of Hemodialysis and Apheresis, The University of Tokyo Hospital, Tokyo, Japan.
Division of Nephrology and Endocrinology, The University of Tokyo School of Medicine, Tokyo, Japan.
Department of Medicine, Kidney Center, Tokyo Women's Medical University, Tokyo, Japan.


Immunoadsorption with a tryptophan-conjugated column has a limited capacity and reduces fibrinogen. We speculated that immunoadsorption with a selective plasma separator has higher efficiency in removing immunoglobulins than ordinary immunoadsorption without affecting coagulation factors. This study investigated the efficacy of immunoadsorption with a selective plasma separator in vitro. The sieving coefficients, the pool concentration, and the adsorbed amount were investigated serially with up to 5 L of processed plasma. The sieving coefficients of the selective plasma separator were 0.8, 0.5, and 0.1 for albumin, immunoglobulin G (IgG), and factor 13, respectively. The trend of concentrations for the ordinary plasma separator in the pool reached its nadir at 1.5 L and 3.5 L of plasma processed for IgG, IgG1, or IgG2, and IgG3, respectively. However, the volume was doubled for the selective plasma separator. The trends of fibrinogen and factor 13 concentrations differed significantly between two plasma separators. The trends of the absorbed amount were mirror images of the concentration in the pool. Comparison of the peak amount absorbed indicated that the amounts were almost identical between the two separators for IgG, IgG1, and IgG2. On the other hand, the peak amounts were less for albumin, fibrinogen, and IgG3 with the selective plasma separator than with the ordinary separator. Although further investigations about bradykinin are required, immunoadsorption with the selective plasma separator supports the administration of more frequent and intensive treatments to remove IgG1 or IgG2 without affecting coagulation factors.


Fibrinogen; Immunoadsorption; Immunoglobulin G; Selective plasma separator

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center